US$ 22.00
melanotic neuroectodermal tumour of infancy histology Frontiers melanotic neuroectodermal tumor of infancy
Description
Liyanage SI, Vilekar P, Weaver DF

For a 2.5 mg target dose: Convert to syringe units

A study of lipid testing intervals for 9000 patients with previous coronary heart disease on pravastatin suggests that, in those who are stable on treatment and below target, testing intervals for lipids could be lengthened to more than a year in view of the size of the combined biological and analytical variation as compared to longer term small fluctuations in cholesterol

Its typically described as light to dark brown in color and semi-solid with a light mucus coating